Home
Home

Simcere

China Biotech In Review: Roche Steps Up As A Bidder For Life Technologies

China Biotech In Review: Roche Steps Up As A Bidder For Life Technologies
Seeking Alpha

China Biotech In Review: Simcere Receives $503 Million Privatization Offer

China Biotech In Review: Simcere Receives $503 Million Privatization Offer
Seeking Alpha

Simcere receives buyout offer from founder, ex CEO

Simcere receives buyout offer from founder, ex CEO
Yahoo/AP

What Simcere Pharmaceutical Group's Earnings Headlines Didn't Tell You

What Simcere Pharmaceutical Group's Earnings Headlines Didn't Tell You
Motley Fool

China Biotech In Review: 2012 China Life Science VC, M&A, And Partnering Climb

China Biotech In Review: 2012 China Life Science VC, M&A, And Partnering Climb
Seeking Alpha

Simcere Pharma sells stake in Shanghai Celgen Bio-Pharmaceutical for about $48 million

Simcere Pharma sells stake in Shanghai Celgen Bio-Pharmaceutical for about $48 million
Yahoo/AP

Here's 1 Reason Simcere Pharmaceutical Group Looks Weak

Here's 1 Reason Simcere Pharmaceutical Group Looks Weak
Motley Fool

Merck Shrugs off Patent Worries, Eyes China

Merck Shrugs off Patent Worries, Eyes China
Motley Fool

China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture

China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture
Seeking Alpha

Don't Get Too Worked Up Over Simcere Pharmaceutical Group's Earnings

Don't Get Too Worked Up Over Simcere Pharmaceutical Group's Earnings
Motley Fool